Vascular & Endovascular

This channel includes news on non-coronary vascular disease and therapies. These include peripheral artery disease (PAD), abdominal and thoracic aortic aneurysm (AAA and TAA), aortic dissection, pulmonary embolism (PE), critical limb ischemia (CLI), carotid artery and stroke interventions, venous interventions, deep vein thrombosis (DVT), and interventional radiology therapies. The focus on most of these therapies is minimally invasive, catheter-based procedures performed in a cath lab.

Thumbnail

Study: Mortality rate 3% for pediatric arterial ischemic stroke

Almost 3 percent of infants and children hospitalized for pediatric arterial ischemic stroke (AIS) die in the hospital, according to a new international study published in the May 2018 edition of Pediatrics.

Thumbnail

Restenosis more common after carotid stenting, linked to stroke risk

Restenosis of the carotid arteries is more likely after stenting than endarterectomy and increases the likelihood of stroke, according to a subanalysis of a randomized trial published in The Lancet Neurology.

Thumbnail

Fast walking speed associated with reduced mortality risk

Putting some extra pep in your step may prolong your life, according to a study published June 1 in the British Journal of Sports Medicine.

Thumbnail

Image-guided atherectomy system gains FDA approval

Avinger announced last week the FDA has approved its next-generation Pantheris Lumivascular atherectomy device, which is used to remove plaque from a blood vessel in those with peripheral artery disease (PAD).

MicroVention® Announces FDA Approval For Neuro Stent Device

ALISO VIEJO, Calif., May 31, 2018 — MicroVention, Inc., a U.S.-based subsidiary of Terumo and a global neurovascular company, announced today the FDA Premarket Approval (PMA) for the LVIS® and LVIS® Jr. stents for stent-assisted coil embolization of intracranial aneurysms.

Thumbnail

Telerehab for arm motor status shows promise in stroke patients

In-home physical therapy using telehealth systems, supervised by a licensed physical therapist, is effective for stroke rehabilitation, according to a study presented May 24 at the 2018 European Stroke Organization Conference in Gothenburg, Sweden.

Thumbnail

DOACs can be safely continued during elective procedures on AFib patients

With shorter half-lives and more predictable effects, direct oral anticoagulants (DOACs) could help simplify perioperative treatment decisions for patients with non-valvular atrial fibrillation (NVAF), suggests a meta-analysis published May 24 in Circulation.

Thumbnail

Severe eczema in adulthood may increase CVD risk by 70%

Severe and active atopic eczema in adulthood is associated with an increased risk for developing cardiovascular disease (CVD), including stroke, heart failure, myocardial infarction (MI) and atrial fibrillation (AFib), according to a new study published May 23 in The BMJ.